Germany’s vaccination committee recommends that AstraZeneca’s Covid-19 vaccine be given only to people between the ages of 18 and 64. “For now there is not enough data available to evaluate the efficacy of the vaccine from 65 years of age”, judge these experts, in a resolution that the German Health Ministry made public on Thursday. “The AstraZeneca vaccine, unlike mRNA vaccines, should only be offered to people aged 18 to 64 at each stage,” they emphasize.
The European Medicines Agency is expected to make a decision on the approval of the vaccine this Friday, so the German movement represents a further step in the escalation of tension between the EU and the pharmaceutical firm.
The reaction of the British Prime Minister has not been long in coming. Boris Johnson has come out in defense of the British vaccine developed with the University of Oxford and has affirmed that the British regulator maintains that it is effective in all age groups.
A spokesman for the pharmaceutical AstraZeneca stressed that the latest data from clinical trials “supports efficacy in the age group over 65 years.” “Our own authorities have made it very clear that the vaccine provides a high degree of protection,” Johnson said.
Indeed, the European Commission has stated this Thursday that AstraZeneca “clearly” corresponds to the task of finding solutions to be able to supply the European Union countries with the doses of the vaccine that it had initially promised to the community club.
“It is clearly up to the company to make proposals on how it plans to comply with the terms of the contract and we will listen to the proposals that come from AstraZeneca. Time will tell what the solutions are,” said the main spokesman for the Community Executive, Eric at a press conference. Mamer.
In the framework of these conversations that both parties are having during the last dates, Brussels has communicated to AstraZeneca its intention to make public the advance purchase contract, but has not yet received a “definitive answer” from the company.